SCHEMBL30664676

SCHEMBL30664676

CC(=O)N(Cc1ccccc1)c1sc2cc(O)ccc2c1C(=O)OC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ TSPO P30536 3/20 0.39
▸ GAA P10253 1/20 0.38
▸ AKR1B1 P15121 1/20 0.38
▸ ESR1 P03372 3/20 0.36
▸ HPGD P15428 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ PDK1 Q15118 3/20 0.36
▸ CA12 O43570 3/20 0.36
▸ CA1 P00915 3/20 0.36
▸ CA2 P00918 3/20 0.36
▸ CA7 P43166 3/20 0.36
▸ CA9 Q16790 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24682961 1.00 POLB (0.39) POLBALDH1A1LMNAMAPTKDM4E
SCHEMBL24682178 0.89 MAPT (0.43) POLBALDH1A1LMNAMAPTKDM4E
SCHEMBL29800041 0.89 MAPT (0.43) POLBALDH1A1LMNAMAPTKDM4E
SCHEMBL29799804 0.88 TSPO (0.44) TSPOESR1PDK1DYRK1AESR2
SCHEMBL24682174 0.88 TSPO (0.44) TSPOESR1PDK1DYRK1AESR2
SCHEMBL24683154 0.87 LMNA (0.45) ALDH1A1LMNAMAPTKDM4ESMN1; SMN2
SCHEMBL29800048 0.87 LMNA (0.45) ALDH1A1LMNAMAPTKDM4ESMN1; SMN2
SCHEMBL24682934 0.86 TSPO (0.39) ALDH1A1LMNAMAPTSMN1; SMN2TSPO
SCHEMBL30664684 0.86 TSPO (0.39) ALDH1A1LMNAMAPTSMN1; SMN2TSPO
SCHEMBL24682202 0.84 PDK1 (0.45) MAPTTSPOESR1PDK1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY OTCPHARM JSC (RU) 2024-05-30 — — US disclosed
EP-4293017-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY Otcpharm JSC (RU) 2023-12-20 — — EP disclosed
CN-117222630-A 2-acetamido-6-hydroxy-benzothiophene derivatives having antiviral activity OTC制药公司(JSC) 2023-12-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240174629-A1 2-ACETAMIDO-6-HYDROXY-BENZOTHIOPHENE DERIVATIVES WITH ANTIVIRAL ACTIVITY ACE2, ACE, EIF2AK2 POLB 1508/4885ALDH1A1 259/4885LMNA 4373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback